Evaluating the upper airway in obstructive sleep apnea using drug-induced sleep endoscopy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of drug-induced sleep endoscopy (DISE) to assess the upper airway in patients with obstructive sleep apnea (OSA) who are considering surgical treatment. It aims to evaluate the reliability of DISE and compare its findings with traditional imaging techniques like lateral cephalogram X-ray. The study also focuses on patients who have not responded to previous sleep apnea surgeries, examining the correlation between DISE findings and surgical outcomes. The intervention involves sedation with propofol to facilitate the endoscopic evaluation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients with OSA considering surgical treatment

Exclusion Criteria:

* Minors
* Pregnant women
* Patients unable to provide informed consent in English themselves
* Prisoners
* Allergy to propofol, soybean oil, egg lecithin or glycerol
* Other contraindication to use of propofol (decision of anesthesiologist or otolaryngologist.)

Where it's running

• UCLA Santa Monica Medical Center
  Santa Monica, California, United States Recruiting

Study contacts

• Principal investigator: Eric J Kezirian, MD, MPH — University of California, Los Angeles
• Study coordinator: Eric J Kezirian, MD, MPH
• Email: ekezirian@mednet.ucla.edu
• Phone: 4242596559

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered sleep staging and sleep apnea screening using multimodal wearable data

  This study tests AI models that use wearable and sensor data to help identify sleep stages and screen for obstructive sleep apnea in adults undergoing standard sleep testing.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07908160

• Jaw advancement with counterclockwise rotation for obstructive sleep apnea

  This trial tests whether jaw advancement surgery with counterclockwise rotation helps people with moderate to severe obstructive sleep apnea who can't tolerate CPAP breathe better and sleep more soundly.

  Recruiting Dalarna County Council, Sweden · Falun, Dalarna County · NCT07446634

• Eloralintide for people with obstructive sleep apnea who are overweight or obese

  This study will test whether the drug eloralintide helps adults with moderate-to-severe obstructive sleep apnea who are overweight or obese, whether they use PAP therapy or not.

  Recruiting at 100 sites Phase 3 Eli Lilly and Company · Cullman, Alabama and 114 other locations · NCT07369011

• Long-term use of a nasopharyngeal airway for obstructive sleep apnea

  This follow-up lets people who finished the parent trial keep using a nasopharyngeal airway to see how it works over the long term for obstructive sleep apnea.

  Recruiting at 2 sites University of Michigan · Ann Arbor, Michigan and 1 other locations · NCT07191314

• How insomnia affects PAP use in children and teens with obstructive sleep apnea.

  This study will see if insomnia makes children and teens with obstructive sleep apnea less likely to stick with positive airway pressure (PAP) therapy.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT07176767

• Does mouth opening change with quality of life after adenotonsillectomy in kids with type 1 OSA?

  This study tests whether improvements in mouth opening after adenotonsillectomy are linked to better quality of life in children with Type 1 Obstructive Sleep Apnea.

  Recruiting Groupe Adène · Saint-Jean-de-Védas · NCT06973928

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.